NFL BIOSCIENCES news, videos and press releases
For more news please use our advanced search feature.
NFL BIOSCIENCES - More news...
NFL BIOSCIENCES - More news...
- NFL BIOSCIENCES: CO-FOUNDER SHAREHOLDER FURTHER STRENGTHENS HIS POSITION BY EXERCISING “BSPCE” WARRANTS
- NFL Biosciences: Recruitment completed for the PRECESTO study
- NFL BIOSCIENCES: Inclusion of the first volunteer in the PRECESTO study
- NFL Biosciences collaborates with the CEA
- NFL BIOSCIENCES: Very successful capital increase for NFL Biosciences with over €3 million raised
- NFL Biosciences launches a round of fundraising for approximately 2.5 million euros
- NFL Biosciences: CESTO II trial progressing on schedule
- NFL BIOSCIENCES: CLINICAL TRIAL APPROVED TO DEMONSTRATE THE COMPLEMENTARITY OF NFL-101 WITH OTHER SMOKING CESSATION TREATMENTS
- NFL BIOSCIENCES HALF-YEAR REVIEW OF THE LIQUIDITY AGREEMENT FOR H1 2022
- NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE
- NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea
- Nfl Biosciences: Half-Year Review of the Liquidity Agreement for h2 2021
- NFL Biosciences: Phase II/III clinical trial launched for smoking cessation
- NFL BIOSCIENCES: agreement signed with Diverchim to manufacture its active ingredients
- NFL Biosciences: Availability of the Half Year Financial Report as of June 30, 2021
- NFL BIOSCIENCES: approval for its patent to be granted in the United States
- Nfl Biosciences Raises €5.0m Following Its Successful Initial Public Offering on Euronext Growth Paris®
